^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
KT095
i
Other names: KT095
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Nanjing KATI
Drug class:
B7-H3-targeted CAR-T immunotherapy
Related drugs:
